News Release: Research, School of Medicine
Mar. 30, 2009
Emory School of Medicine Names New Executive Associate Dean for Research
Raymond J. Dingledine, PhDRaymond J. Dingledine, PhD, professor and chair of the Department of Pharmacology in Emory University School of Medicine, has been named the school's Executive Associate Dean for Research. He also will continue to serve as chair of pharmacology, a role he has held since 1992 when joining Emory from the University of North Carolina, Chapel Hill.
Dingledine brings considerable experience to his new position, having served as interim executive associate dean for research in the School of Medicine. He has co-authored two highly successful research strategic plans and currently is spearheading the development of the school's new research strategic plan.
"Ray Dingeldine's leadership in program building, funding initiatives and coordination of research space throughout the School of Medicine, as well as his leadership skills and ability to bring consensus on projects crossing multiple departments and schools has been demonstrated repeatedly," says Thomas J. Lawley, MD, dean, Emory University School of Medicine. "His vision, energy and expertise have served the School of Medicine well and I am confident will continue to do so in the future."
Dingledine has a long track record as an outstanding scientist and scientific administrator. He is nationally recognized as an expert in neurosciences and is a scientific thought leader both locally and nationally. His research focuses on signaling pathways in the brain, integrating a variety of experimental strategies aimed at a better understanding of epilepsy, with broad implications for other brain disorders including stroke and schizophrenia.
He received his PhD from Stanford University in 1975 and was a postdoctoral fellow at the University of Cambridge, England and the University of Oslo, Norway. He was on the pharmacology faculty at the University of North Carolina, Chapel Hill from 1978 to 1992 and was a visiting scientist at the Salk Institute from 1990 to 1991.
His scientific papers have been highlighted in numerous scientific journals, including Nature Medicine in 2002. He has served as editor of Molecular Pharmacology; associate editor of the Journal of Neuroscience, and on the editorial boards of NeuroMolecular Medicine, Molecular Interventions, Epilepsia, Neuropharmacology, the Journal of Molecular Neuroscience and Epilepsy Research.
In addition to his extensive bibliography, Dingledine has presented his work in distinguished lectures and professional meetings all over the world.
His numerous honors include election to the Scientific Council of the National Institute of Neurological Disorders and Stroke (NINDS), election as a fellow in the American Association for the Advancement of Science (AAAS), the Jacob Javits Award in the Neurosciences from the NINDS, and the Epilepsy Basic Research Award from the American Epilepsy Society.
A skilled educator, Dingledine has mentored 12 PhD students and 28 postdoctoral fellows, all of whom hold academic or industry positions.
###
The Robert W. Woodruff Health Sciences Center of Emory University is an academic health science and service center focused on missions of teaching, research, health care and public service. Its components include schools of medicine, nursing, and public health; Yerkes National Primate Research Center; the Emory Winship Cancer Institute; and Emory Healthcare, the largest, most comprehensive health system in Georgia. The Woodruff Health Sciences Center has a $2.3 billion budget, 17,000 employees, 2,300 full-time and 1,900 affiliated faculty, 4,300 students and trainees, and a $4.9 billion economic impact on metro Atlanta.
Learn more about Emory’s health sciences:
Blog: http://emoryhealthblog.com
Twitter: @emoryhealthsci
Web: http://emoryhealthsciences.org
